DBV Technologies SA

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2021 

04 Nov 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021

01 Nov 2021 02:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments

26 Oct 2021 16:15:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021

12 Oct 2021 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2021

08 Sep 2021 16:00:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate at Upcoming Investor Conferences

31 Aug 2021 01:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2021

09 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

06 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments

02 Aug 2021 16:15:00 By Nasdaq GlobeNewswire

DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021

26 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021

07 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2021

15 Jun 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at Upcoming Investor Conferences

02 Jun 2021 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its Board of Directors

19 May 2021 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2021

17 May 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021

05 May 2021 17:00:00 By Nasdaq GlobeNewswire

DBV Technologies Reports Q1 2021 Financial Results

03 May 2021 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming Investor Conferences

29 Apr 2021 01:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company

28 Apr 2021 16:30:00 By Nasdaq GlobeNewswire

Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic

28 Apr 2021 01:30:00 By Nasdaq GlobeNewswire